Literature DB >> 11502292

Tamponade-balloon for obstetrical bleeding.

Y N Bakri1, A Amri, F Abdul Jabbar.   

Abstract

OBJECTIVES: To study the effectiveness of a large volume, fluid-filled tamponade balloon in the management of post-partum hemorrhage originating from the implantation site of low-lying placenta/placenta previa.
METHODS: A silicone, fluid-filled balloon was designed for tamponade function, with a filling capacity volume of 500 cc of sterile saline, and strength to withstand a maximum internal and external pressure of 300 mmHg. Five women with postpartum bleeding caused by low-lying placenta/placenta previa, and one woman with cervical ectopic pregnancy, underwent a tamponade balloon insertion as a conservative measure in the management of bleeding.
RESULTS: The tamponade balloon was used in five women with post-partum bleeding caused by low-lying placenta/placenta previa, and in one woman with cervical pregnancy. The balloon was effective in controlling post-partum hemorrhage originating from the placental site of the lower uterine segment, and bleeding from the implantation site of cervical ectopic pregnancy.
CONCLUSION: Hemostasis in cases of post-partum bleeding caused by low-lying placenta/placenta previa can be achieved by using a large volume, fluid-filled tamponade balloon.

Entities:  

Mesh:

Year:  2001        PMID: 11502292     DOI: 10.1016/s0020-7292(01)00395-2

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  28 in total

1.  Dilation of the vaginal cuff using the Bakri Postpartum Balloon to extract the large uterus at the time of robotic hysterectomy for endometrial carcinoma.

Authors:  Michael L Stitely; Younes N Bakri
Journal:  J Robot Surg       Date:  2011-03-16

2.  Cesarean scar dehiscence associated with intrauterine balloon tamponade placement after a second trimester dilation and evacuation.

Authors:  Reni Soon; Tod Aeby; Bliss Kaneshiro
Journal:  Hawaii Med J       Date:  2011-07

Review 3.  Role of Balloon Tamponade as a Therapeutic Non-Surgical Tool in Controlling Obstetric and Gynecological Hemorrhage in Low-Resource Countries.

Authors:  C N Purandare; Amala Khopkar Nazareth; Gillian Ryan; Nikhil C Purandare
Journal:  J Obstet Gynaecol India       Date:  2022-06-01

4.  Uterine rupture complicating sequential curettage and Bakri balloon tamponade to control secondary PPH.

Authors:  Olukunle Adegboye Ajayi; Manjusha Sant; Sunday Ikhena; Abdumalik Bako
Journal:  BMJ Case Rep       Date:  2013-02-06

5.  Endovascular treatment in postpartum haemorrhage.

Authors:  G Mansueto; A Contro; G Carbognin; F Liessi; G Zanconato; M Franchi; R Pozzi Mucelli
Journal:  Radiol Med       Date:  2012-05-14       Impact factor: 3.469

6.  Experience with different techniques for the management of postpartum hemorrhage due to uterine atony: compression sutures, artery ligation and Bakri balloon.

Authors:  Y Cekmez; E Ozkaya; F D Öcal; T Küçüközkan
Journal:  Ir J Med Sci       Date:  2014-05-15       Impact factor: 1.568

7.  Mechanical and surgical interventions for treating primary postpartum haemorrhage.

Authors:  Frances J Kellie; Julius N Wandabwa; Hatem A Mousa; Andrew D Weeks
Journal:  Cochrane Database Syst Rev       Date:  2020-07-01

8.  Emergent management of postpartum hemorrhage for the general and acute care surgeon.

Authors:  Allison B Weisbrod; Forest R Sheppard; Mildred R Chernofsky; Charles L Blankenship; Frederick Gage; Gary Wind; Eric A Elster; William A Liston
Journal:  World J Emerg Surg       Date:  2009-11-25       Impact factor: 5.469

9.  The uterine sandwich method for placenta previa accreta in mullerian anomaly: combining the B-lynch compression suture and an intrauterine gauze tampon.

Authors:  Mustafa Kaplanoğlu
Journal:  Case Rep Obstet Gynecol       Date:  2013-03-31

10.  Efficacy of Intrauterine Bakri Balloon Tamponade in Cesarean Section for Placenta Previa Patients.

Authors:  Hee Young Cho; Yong Won Park; Young Han Kim; Inkyung Jung; Ja-Young Kwon
Journal:  PLoS One       Date:  2015-08-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.